Drug-related Database Query & Data Integration

AI-Enhanced Database Mining, Knowledge Graph Construction & Multi-Omics Integration. From Fragmented Data to Validated Hypotheses.
NLP-Driven Literature Mining Knowledge Graph Neural Networks Wet-Lab Validation

MagHelix™ unifies siloed drug data from ChEMBL, PubChem, and PDB into AI-built knowledge graphs, delivering wet-lab validated hypotheses.

Why Drug-related Database Query Is the Critical Bridge Between Data and Discovery?

Public databases hold millions of bioactivity points, yet they remain siloed. ChEMBL has small-molecule data; PDB has structural snapshots; LINCS has transcriptomic signatures. For virtual biotechs without a data science team, even a simple target lookup becomes a week-long manual exercise. For pharma teams, internal ELN data never meets external intelligence. The MagHelix™ platform closes this gap: we construct queryable knowledge graphs from heterogeneous sources, apply graph neural networks and NLP to predict novel drug-target-disease associations, and hand off ranked hypotheses to Molecular Docking Services and Hit Biophysical Characterization for orthogonal validation.

What Sets the Platform Apart

AI-Driven Knowledge Graphs

Graph neural networks and NLP models extract drug-target-disease relationships from ChEMBL, DrugBank, and biomedical literature, building queryable knowledge graphs.

Multi-Omics Integration

Transcriptomic, genomic, and proteomic datasets are harmonized with chemical structure databases to reveal polypharmacology and off-target liabilities.

Wet-Lab Validation Loop

Database-derived hypotheses proceed directly to SPR/BLI validation and Molecular Docking Services.

The Database Query & Integration Suite

Contents

Multi-Database Query & Knowledge Graph Construction

Unify ChEMBL, PubChem, DrugBank, and PDB into Queryable Intelligence

Multi-omics data integration pipeline showing genomic, transcriptomic, and proteomic data streams converging into a unified molecular structure.
  • Structured & Unstructured Data Mining — Automated querying of ChEMBL, PubChem, DrugBank, PDB, BindingDB, and patent databases via APIs and web services.
  • Knowledge Graph Construction — Neo4j-based graph databases linking drugs, targets, diseases, and pathways with semantic relationships.
  • Ideal For — Target identification, drug repurposing, competitive landscape analysis, and De Novo Drug Design seeding.

For biotechs without database infrastructure, we deliver a queryable knowledge graph within one week. For pharma, graphs integrate with internal ELN and CDD Vault via automated pipelines.

Bioinformatics Data Integration & Pipeline Orchestration

Harmonize Genomics, Transcriptomics, and Proteomics with Chemical Data

AI-powered literature mining interface extracting drug-target interactions from scientific documents and patent structures.
  • Multi-Omics Harmonization — Integration of genomics, transcriptomics (CMap/LINCS), proteomics, and metabolomics with chemical bioactivity data.
  • Pipeline Automation — KNIME-based workflows connecting public databases to internal ELN and MagHelix™ CADD Platform.
  • Ideal For — Mechanism-of-action studies, biomarker discovery, and patient stratification for precision oncology.

When combined with ADMET Prediction & Modeling, multi-omics integration flags off-target liabilities before synthesis commitment.

AI-Enhanced Data Mining & Predictive Analytics

Predict Drug-Disease Associations from Integrated Knowledge Graphs

Graph neural network prediction model highlighting novel drug-disease associations with confidence scoring gradients.
  • NLP Literature Mining — Large language models extract drug-target interactions, adverse events, and repurposing signals from PubMed and clinical trial registries.
  • Graph Neural Network Prediction — GNN models predict novel drug-disease associations and off-target profiles from integrated knowledge graphs.
  • Ideal For — ADMET liability flagging, polypharmacology profiling, and Hit Identification prioritization.

AI-predicted hypotheses feed directly into Structure-Based Virtual Screening (SBVS) and Ligand-Based Virtual Screening (LBVS) for consensus ranking.

Platform Instrumentation

Software / System Core Capability
Neo4j / Amazon Neptune Knowledge graph construction and graph database query for drug-target-disease networks.
RDKit / ChEMBL Web Services Chemical structure standardization and bioactivity data extraction from public repositories.
KNIME / Pipeline Pilot Automated multi-source data integration workflows and ELN connectivity.
Biacore 8K / S200 High-throughput SPR binding confirmation for database-derived drug-target hypotheses.
Octet RED96e Label-free BLI screening for rapid validation of predicted protein-ligand interactions.
NVIDIA DGX / A100 Cluster Large-scale graph neural network and NLP model training on integrated datasets.
CDD Vault / Dotmatics Internal data management and seamless handoff to Hit Biophysical Characterization.

Standardized Workflow

Project Workflow

A standardized, milestone-driven execution system. From database audit to validated hypotheses—managed by a single computational project team, tracked in real time.

01 Database Audit & Query Design Week 1
02 Data Harmonization & Integration Week 1
03 Knowledge Graph Construction Weeks 2–3
04 AI Mining & Hypothesis Generation Weeks 3–4
05 Validation & Handoff Week 4–5

01 Database Audit & Query Design

  • Define data sources: ChEMBL, PubChem, PDB, internal ELN.
  • Assess coverage gaps and data quality.
  • Design query strategy across structured and unstructured databases.

Deliverable: Data source audit + query strategy.

02 Data Harmonization & Integration

  • Extract and standardize bioactivity, structural, and omics data.
  • Resolve chemical ambiguities and ID mapping.
  • Harmonize multi-source datasets into unified schema.

Deliverable: Harmonized multi-source dataset.

03 Knowledge Graph Construction

  • Build knowledge graph with drug-target-disease-pathway nodes.
  • Validate topology against known benchmarks.
  • Establish semantic relationships and queryable endpoints.

Deliverable: Queryable knowledge graph + topology report.

04 AI Mining & Hypothesis Generation

  • Deploy NLP and GNN models for repurposing and liability prediction.
  • Rank hypotheses by confidence scores.
  • Cross-validate predictions against literature and known data.

Deliverable: Ranked hypothesis list with AI confidence scores.

05 Validation & Handoff

Deliverable: Final report + validation plan + transition to wet-lab.

Sample Requirements

Requirement Details
Target or disease Target name, UniProt ID, disease indication, or pathway of interest
Data scope Public databases only, or integration with internal ELN/HTS/DEL data
Prior data Internal bioactivity, ADMET, or omics datasets for graph enrichment
Project scope Target identification, drug repurposing, liability assessment, or competitive analysis
Output preference Knowledge graph file, API endpoint, or integrated dashboard

Standard Deliverables

  • Queryable knowledge graph (Neo4j format or API) with full provenance
  • Harmonized multi-source dataset with chemical structure standardization
  • AI-predicted drug-target-disease association list with confidence scores
  • Literature mining report with extracted mechanisms and adverse events
  • Electronic data package for MagHelix™ CADD Platform integration
  • Direct handoff to Molecular Docking Services, SBVS, or Hit Biophysical Characterization

Frequently Asked Questions

Case Study

Case Study: Knowledge Graph and Graph Regularized Integration for Drug Repositioning

Published Evidence:
Luo H, et al. KGRDR: a deep learning model based on knowledge graph and graph regularized integration for drug repositioning. Front Pharmacol. 2025;16:1525029.

Key Findings:

  • Graph-regularized multi-similarity integration eliminated noise from heterogeneous drug and disease data sources.
  • Biomedical knowledge graph construction captured topological relationships between drugs, diseases, and biological entities.
  • Attention-based feature fusion combined similarity and topological features for robust drug-disease interaction prediction.

Industrial Translation:
The Frontiers in Pharmacology research team demonstrates that knowledge graph-based integration of multi-source drug and disease databases significantly improves repositioning accuracy. For seed-stage biotechs, this eliminates manual literature mining across disconnected repositories. For pharma teams, the graph-regularized approach reduces noise in heterogeneous data, yielding higher-confidence repurposing hypotheses. Our MagHelix™ platform operationalizes this peer-reviewed paradigm by pairing knowledge graph construction with ADMET Prediction & Modeling and Hit Biophysical Characterization, delivering validated hypotheses rather than raw data.

Figure 1. Comparison of multiple similarity network fusion methods. (Luo H, et al. 2025)

Reference

  1. Luo H, et al. KGRDR: a deep learning model based on knowledge graph and graph regularized integration for drug repositioning. Front Pharmacol. 2025;16:1525029.

Need AI-enhanced database query and data integration to accelerate your target identification or repurposing pipeline? Our team can design a customized knowledge graph and mining strategy tailored to your target class, data assets, and milestones. Contact our scientific team today.